Literature DB >> 21927016

SHP gains citizenship of the AMPK kingdom.

Hun-Taeg Chung1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21927016      PMCID: PMC4012926          DOI: 10.1038/cmi.2011.39

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  9 in total

Review 1.  Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential.

Authors:  Ananta Paine; Britta Eiz-Vesper; Rainer Blasczyk; Stephan Immenschuh
Journal:  Biochem Pharmacol       Date:  2010-07-17       Impact factor: 5.858

Review 2.  AMP-activated protein kinase and its downstream transcriptional pathways.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

3.  Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival.

Authors:  Xiao-ming Liu; Kelly J Peyton; Ahmad R Shebib; Hong Wang; Ronald J Korthuis; William Durante
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

Review 4.  Negative regulation of toll-like receptor-mediated immune responses.

Authors:  Foo Y Liew; Damo Xu; Elizabeth K Brint; Luke A J O'Neill
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

Review 5.  Pathogen recognition by the innate immune system.

Authors:  Himanshu Kumar; Taro Kawai; Shizuo Akira
Journal:  Int Rev Immunol       Date:  2011-02       Impact factor: 5.311

6.  The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors.

Authors:  Jae-Min Yuk; Dong-Min Shin; Hye-Mi Lee; Jwa-Jin Kim; Sun-Woong Kim; Hyo Sun Jin; Chul-Su Yang; Kyeong Ah Park; Dipanjan Chanda; Don-Kyu Kim; Song Mei Huang; Sang Ki Lee; Chul-Ho Lee; Jin-Man Kim; Chang-Hwa Song; Soo Young Lee; Gang Min Hur; David D Moore; Hueng-Sik Choi; Eun-Kyeong Jo
Journal:  Nat Immunol       Date:  2011-07-03       Impact factor: 25.606

Review 7.  Toll-like receptors: linking inflammation to metabolism.

Authors:  A Christine Könner; Jens C Brüning
Journal:  Trends Endocrinol Metab       Date:  2010-10-01       Impact factor: 12.015

Review 8.  AMPK: an emerging drug target for diabetes and the metabolic syndrome.

Authors:  Bei B Zhang; Gaochao Zhou; Cai Li
Journal:  Cell Metab       Date:  2009-05       Impact factor: 27.287

Review 9.  AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan.

Authors:  Antero Salminen; Juha M T Hyttinen; Kai Kaarniranta
Journal:  J Mol Med (Berl)       Date:  2011-03-23       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.